Loading...

Length 
187 pages

Date published 
August 2009

Additional info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.




Loading...

Country, Global license:
Contact Jack Valeri,
Global Report Sales
781-972-1355

Corporate subscriptions:
Contact David Cunningham,
Global Report Sales
781-972-5472

Questions?
Contact Rose LaRaia
Customer Service
781-972-5444

Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn Add to Twitter EMail Page Printer Friendly Book Mark

Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment Tables and Figures

Loading...

 

Author: Mark C. Via

FIGURES
Figure 1.1. Structure of an Antibody
Figure 2.1. Monoclonal Antibody Production
Figure 2.2. Antibody Engineering
Figure 2.3. Engineered Forms of Antibodies

TABLES
Table 3.1. FDA-Approved Therapeutic Monoclonal Antibodies
Table 3.2. Unconjugated Monoclonal Antibodies in Clinical Trials for Cancer
Table 3.3. Conjugated Monoclonal Antibodies in Clinical Trials for Cancer
Table 3.4. Monoclonal Antibodies in Clinical Trials for Immunological Diseases
Table 3.5. Monoclonal Antibodies in Clinical Trials for Infectious Diseases
Table 3.6. Monoclonal Antibodies in Clinical Trials for Cardiovascular Diseases
Table 3.7. Other Therapeutic Monoclonal Antibodies in Clinical Development
Table 4.1. Worldwide Sales of Therapeutic Monoclonal Antibodies, 2007 and 2008
Table 4.2. Estimated New Cancer Cases in United States, Total and Selected Types, 2009